Posted by Joseph Griffin on May 12th, 2024
Insmed (NASDAQ:INSM – Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.06) EPS for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.16, Briefing.com...
More of this article »